Stay updated on MGD013 and Brivanib in Liver Cancer Clinical Trial
Sign up to get notified when there's something new on the MGD013 and Brivanib in Liver Cancer Clinical Trial page.

Latest updates to the MGD013 and Brivanib in Liver Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe ClinicalTrials.gov page footer now identifies the site revision as v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedA site-wide notice explains NIH’s transition from the term “Artificial Intelligence” to “Super Intelligence,” and the displayed site revision advances to v3.7.2.SummaryDifference0.9%

- Check29 days agoChange DetectedThe footer revision number was updated from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check50 days agoChange DetectedThe Study Record Versions list now includes the latest revision, v3.7.0, and removes the previous revision, v3.6.6, reflecting an update to the page's history.SummaryDifference0.1%

- Check64 days agoChange DetectedA new revision entry, v3.6.6, has been added to the study record history. The previous revision entry, v3.6.5, has been removed from the list.SummaryDifference0.1%

- Check85 days agoChange DetectedA new revision label v3.6.5 is added to the study record history and the previous label v3.6.4 is removed, updating the page's version history.SummaryDifference0.1%

Stay in the know with updates to MGD013 and Brivanib in Liver Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MGD013 and Brivanib in Liver Cancer Clinical Trial page.